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Inherited mutations in the mitochondrial (mt)DNA are a major cause of human disease, with approximately 1 in
5000 people affected by one of the hundreds of identified pathogenic mtDNA point mutations or deletions. Due
to the severe, and often untreatable, symptoms of many mitochondrial diseases, identifying how these muta-
tions are inherited from one generation to the next has been an area of intense research in recent years.
Despite large advances in our understanding of this complex process, many questions remain unanswered, with
one of the most hotly debated being whether or not purifying selection acts against pathogenic mutations dur-
ing germline development.
Mitochondrial DNA mutation: homoplasmy
versus heteroplasmy
The mammalian mitochondrial (mt)DNA genome con-
sists of a circular, double-stranded loop of DNA varying
from 15 000 to 17 000 bp in length depending on the
species, with the human mtDNA sequence containing
16 569 bp (Chinnery & Hudson 2013). The mtDNA con-
tains 37 genes, encoding 13 subunits of the electron
transport chain (ETC), which contribute to the produc-
tion of energy in the cell via oxidative phosphorylation
(OXPHOS); and 24 RNA, comprising 22 tRNA and two
ribosomal RNA (16S RNA and 12S RNA), required for
the transcription and translation of mtDNA-encoded
proteins (Chinnery & Hudson 2013). Unlike the nuclear
genome, mammalian mtDNA is inherited uniparentally,
solely via the maternal line, and does not undergo
recombination (Hagstrom et al. 2014). mtDNA is pre-
sent in multiple copies within each cell, and copy num-
ber varies from 100 to 10 000 copies, adapting to the
cellular needs in a tissue-specific manner (Chinnery &
Hudson 2013). mtDNA has a much higher mutation rate
than the nuclear genome, possibly due to the close
proximity of mtDNA to mutagenic reactive oxygen spe-
cies (ROS) (Lagouge & Larsson 2013), continuous repli-
cation of mtDNA in post-mitotic cells, with an error rate
several orders of magnitude higher than in the nucleus
(Johnson & Johnson 2001), or a less extensive array of
DNA repair mechanisms (Kazak et al. 2012; Scheibye-
Knudsen et al. 2015) compared with the nucleus. Novel
mtDNA mutations invariably lead to a heterogenic state
termed “heteroplasmy”, where wild-type molecules
coexist with mutated mtDNA molecules in the same cell,
in contrast to the normal state of “homoplasmy”, where
all copies of mtDNA present in the cell share the same
sequence (Fig. 1A).
mtDNA mutations and purifying selection
throughout evolution
In 1964, Muller postulated that asexual inheritance of
DNA without recombination should lead to the accu-
mulation and fixation of deleterious mutations. In the
absence of purifying selection to remove these muta-
tions, this process will ultimately result in mutational
meltdown of the genome, a hypothesis known as
“Muller’s ratchet” (Muller 1964). Evidence of this pre-
dicted build-up of mutations in mtDNA can be seen in
phylogenetic data from human lineages. In theory, all
human mtDNA can be traced back to a single woman,
the so-called “Mitochondrial Eve”, who lived in Africa
approximately 200 000 years ago (Cann et al. 1987).
Since that time the mtDNA genome has been con-
stantly acquiring point mutations, resulting in the
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development of a number of discrete haplogroups,
each defined by a specific subset of variants (Torroni
et al. 1997; Wallace et al. 1999). It is important to note
that each of these variants must first have existed as a
heteroplasmic mutation, before becoming fixed homo-
plasmic polymorphisms, and some mitochondrial dis-
eases, such as Leber hereditary optic neuropathy, are
primarily caused by homoplasmic mutations (Yu-Wai-
Man et al. 2002). Despite the presence of fixed vari-
ants in the mitochondrial genome, which in rare cases
can be pathogenic, many mtDNA-related mitochon-
drial diseases are caused by heteroplasmic point
mutations in the mtDNA coding sequence, which
disrupt ETC activity and lead to mitochondrial dysfunc-
tion (Stewart & Chinnery 2015). However, it is impor-
tant to note that heteroplasmic mutations can either
be inherited or acquired through de novo somatic
mutation during embryogenesis or postnatal develop-
ment. Although homoplasmic variants may be selected
against at the population level (Stewart et al. 2008a),
heteroplasmic mutations can additionally be subject to
purifying selection within individuals and during trans-
mission from generation to generation (Li et al. 2016),
allowing them to be removed from the population
before becoming fixed in the mtDNA sequence. The
fact that relatively few highly deleterious variants have
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Fig. 1. mtDNA heteroplasmy and its transmission through the female germline. (A) Each cell contains multiple mtDNA molecules, a
mutation in the mtDNA (red circles) is termed homoplasmic if all copies carry the mutation, or heteroplasmic if only a proportion carry it.
(B) In heteroplasmic cells, as the burden of a pathogenic mutation (red figures) increases compared to wildtype mtDNA (green figures), a
biochemical threshold is reached. Beyond this point the cell can no longer compensate for the mutation and a respiratory chain defect
develops. The severity of this defect tends to worsen with further increase in the levels of mutant mtDNA. (C) Schematic representation
of female germline development during embryogenesis, and associated events determining the differential segregation of heteroplasmic
mtDNA variants. Whilst the contribution of purifying selection to this process is controversial, such mechanisms could be active from the
initial decrease in cellular mtDNA copy number leading up to the genetic bottleneck, during PGC specification and development and
through oogenesis into adult life.
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become fixed in the mtDNA genome, in spite of its ele-
vated mutation rate, suggests that purifying selection
against such mutations must be active, preventing the
rapid advancement of Muller’s ratchet (Rand & Kann
1996, 1998; Elson et al. 2004; Rand 2008).
The efficiency of purifying selection cannot be 100%,
because deleterious heteroplasmies are found relatively
commonly in the general population (Elliott et al. 2008;
Payne et al. 2013), and novel heteroplasmies have
been repeatedly allowed to fix in the mtDNA genome
throughout evolution, thus “escaping” selection alto-
gether. Additionally, the mutations that “escape” selec-
tion are not merely neutral variants, as many of the
haplogroup polymorphisms found in human mtDNA
are non-synonymous and potentially affect mitochon-
drial function (Kazuno et al. 2006; Pello et al. 2008;
Gomez-Duran et al. 2010). It has been suggested that
positive selection of advantageous mtDNA variants
may explain the presence of some haplogroup poly-
morphisms. The founding mutations of several hap-
logroups appear to be linked to major migratory events
during human colonization of the globe, and might
have allowed survival in colder climates as our ances-
tors moved out of Africa (Coskun et al. 2003; Mishmar
et al. 2003; Ruiz-Pesini et al. 2004); however, this the-
ory is controversial and not universally accepted (Elson
et al. 2004; Kivisild et al. 2006). Whilst it is tempting to
envisage a simple model where advantageous hetero-
plasmies are retained and become fixed, and deleteri-
ous variants are purged, this is clearly not the case.
Some haplogroup-specific variants have been shown
to predispose to certain diseases (Hudson et al. 2013,
2014; Jimenez-Sousa et al. 2015), with some affecting
individuals during reproductive life. Therefore, a bal-
ance clearly exists between the appearance of novel
heteroplasmic mtDNA mutations and subsequent
selection against the most pathogenic of these vari-
ants.
Potential modes of purifying selection
There are a number of levels at which this process of
purifying selection could occur (Rand 2001). In addition
to the aforementioned selection at the population level,
mtDNA mutations may be selected against at the level
of individual organisms, via classical Darwinian selec-
tion, with higher levels of mutation resulting in reduced
fitness and less chance of passing the mutation to the
subsequent generation. At the cellular level, variations
in mutational load between cells will result in selection
against those cells that are least fit (i.e. carry the high-
est levels of mutation) (Rajasimha et al. 2008). This
variation may originate either when cells divide, or dur-
ing replication of mtDNA genomes in post-mitotic cells
(Chinnery & Samuels 1999). Because mtDNA replica-
tion is an ongoing process, even in non-dividing cells,
segregation is active in all tissues throughout life (Burg-
staller et al. 2014), and purifying selection may there-
fore play an important role at all stages. Finally,
selection may also occur at the subcellular level,
potentially through preferential replication of a subset
of mtDNA within the cell prior to division (Blok et al.
1997).
When considering the transmission of heteroplasmic
mtDNA mutations, the development of the maternal
germline is a unique and intriguing step, as it repre-
sents the point at which the single cell and the whole
organism converge. Therefore, any selective mecha-
nisms active on the mtDNA at this stage have huge
potential to influence the integrity of the mtDNA gen-
ome in subsequent generations. This is one of the
reasons that germline inheritance of heteroplasmy has
been such an intense area of research in recent
years, and perhaps one of the most important
advances in this field has been the development of
the germline genetic bottleneck theory of mtDNA
inheritance.
Maternal inheritance of mtDNA
heteroplasmy: the genetic bottleneck theory
In patients carrying potentially deleterious heteroplas-
mic mtDNA mutations, the severity of disease symp-
toms tends to correlate with the level of heteroplasmy,
and if a certain biochemical threshold is reached the
individual will develop pathogenic phenotypes (Fig. 1B)
(Chinnery et al. 1997; DiMauro & Schon 2001). Very
low level mtDNA heteroplasmy appears to be universal
in the human population (Payne et al. 2013), and more
than 1:200 healthy live births carry a point mutation
present at a more than 1% heteroplasmy level (Elliott
et al. 2008). Because mtDNA is strictly maternally
inherited (Hutchison et al. 1974; Case & Wallace 1981;
Pyle et al. 2015) and the heteroplasmy level transmit-
ted from a mother to her offspring varies significantly
(Larsson et al. 1992; Blok et al. 1997), providing prog-
nostic advise to healthy women carrying a pathogenic
mtDNA mutation is currently very challenging (Poulton
et al. 2010; Chinnery et al. 2014).
Shifts in heteroplasmy between a mother and her
offspring were first observed in Holstein cows harbor-
ing two mitochondrial genotypes, distinguished by a
single point mutation. In a single maternal lineage, sig-
nificant heteroplasmy shifts were observed within a
few generations (Hauswirth & Laipis 1982). Hauswirth
and Laipis suggested that such variation could be due
to a dramatic reduction of the mtDNA copy number
during oogenesis, resulting in an increased likelihood
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of heteroplasmy segregation by genetic drift: the so-
called “genetic bottleneck” theory. This change in copy
number was later evaluated in mice and shown to
decrease from 100 000 copies in the fertilized oocyte
to just 200 copies in the PGC, with an estimated 40
mitochondria per cell containing five mtDNA molecules
each at this stage (Fig. 1C) (Nass 1966; Nogawa et al.
1988; Jenuth et al. 1996). This mtDNA bottleneck
effect in the PGC has since been corroborated by
computational simulation and quantitative PCR mea-
surements at the single cell level (Cree et al. 2008;
Wai et al. 2008). Nonetheless, this theory remains con-
troversial because additional work utilizing the same
animal model failed to show such a drastic decrease
in the mtDNA copy number, with the lowest mtDNA
content estimated to be approximately 1500 copies
per cell (Cao et al. 2007, 2009).
The mtDNA germline genetic bottleneck seems to
be present in other vertebrate species. In zebrafish,
Otten et al. measured the mtDNA copy number during
embryogenesis, from fertilized oocyte to PGC. They
observed a marked decrease from 2.0 9 107 copies
per cell in the fertilized oocyte to 170 copies per cell in
the PGC (Otten et al. 2016), suggesting a strong bot-
tleneck effect, similar to that observed in mice. Mea-
surements of mtDNA copy number have also been
performed at later stages during oogenesis in mam-
malian species. In sheep, Cotterill et al. compared the
mtDNA content at the primordial follicle stage to the
metaphase II oocyte stage. They observed an increase
from 605 copies per cell in the primordial follicle to
7.5 9 105 copies per cell in mature oocytes, suggest-
ing a bottleneck event following the primordial follicle
stage (Cotterill et al. 2013). It is interesting to note that,
even though the primordial follicle stage occurs later
than the PGC specification during the embryogenesis,
the mtDNA copy number observed in this study
remains lower than the measurements performed by
Cao et al. (2007).
Thus, numerous independent studies point toward
the genetic sampling event during oogenesis that was
first proposed by Hauswirth and Laipis (1982). The
reduction of mtDNA copy number is predicted to lead
to a shift in heteroplasmy that can happen within a
few generations (Hauswirth & Laipis 1982; Jenuth
et al. 1996; Cree et al. 2008). However, over 30 years
since this hypothesis was first put forward, the exact
timing of the mtDNA copy number decrease during
oogenesis and its impact on heteroplasmy shifts
between generations remains elusive. Wai et al. (2008)
did not observe significant differences between the
level of heteroplasmy of female mice and the PGC of
their progeny, as had previously been suggested
(Hauswirth & Laipis 1982; Jenuth et al. 1996). Instead,
they found that shifts in heteroplasmy appeared to
occur during postnatal folliculogenesis. The authors
suggested that this “late” genetic bottleneck was due
to the replication of a subpopulation of mtDNA mole-
cules during the maturation phase of the follicles (Wai
et al. 2008). The observation by Cao et al. that mouse
PGC contained higher mtDNA copy number than pre-
viously predicted (1500 copies, compared with the
200 copies reported by Cree et al.) led to a third bot-
tleneck theory, involving unequal segregation of the
mtDNA molecules during cell division, rather than a
drastic reduction in copy number (Cao et al. 2007;
Cree et al. 2008). However, direct evidence supporting
this mechanism is lacking. More recently, Freyer et al.
(2012) investigated the timing of heteroplasmy
changes of novel mtDNA mutations by backcrossing a
female mouse carrying a PolgA exo mutation (also
called the mtDNA mutator mouse (Trifunovic et al.
2004)) with wild-type males. Using this method, they
obtained a maternal lineage carrying an m.3875delC in
the tRNAMet gene. Measurement of heteroplasmy
levels in maternal cells, embryonic PGC and oocytes/
soma of the offspring suggested a shift of hetero-
plasmy occurring during the early stages of PGC
development, lending further support to the “early”
bottleneck hypothesis (Freyer et al. 2012).
These contrasting observations highlight the current
ambiguity concerning the timing and mechanism of
the mitochondrial germline genetic bottleneck. The dif-
ferences may, in part, reflect true biological differences
between different strains and species. However, an
alternative explanation is that technical differences,
due to the measurement of low quantities of mtDNA in
single cells, or the precise timing of the observations
during development, could contribute to the different
results reported. However, whatever the precise
underlying process may be, the unpredictable shifts in
heteroplasmy transmitted from mothers carrying
pathogenic mutations to their children continue to
make this area of research highly relevant. One key
question that remains unanswered is whether or not
the germline genetic bottleneck plays a role in selec-
tion against deleterious mtDNA heteroplasmies during
transmission of the mtDNA from mother to offspring
(Fig. 1C).
Evidence for and against purifying selection
in mouse pedigrees
Much work on germline transmission of mtDNA has
utilized invertebrate model organisms, including Droso-
phila (Hill et al. 2014; Ma et al. 2014) and Caenorhab-
ditis elegans (Wernick et al. 2016). However, whilst
these species provide tractable models for such
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studies, they are far removed from humans in evolu-
tionary terms, and so here we focus on data from a
range of studies in mammals that have attempted to
address the role (if any) of purifying selection in inheri-
tance of mtDNA heteroplasmies.
Transmission of mtDNA has been studied in a num-
ber of mammalian species, including cows, sheep and
zebrafish, but many of the studies to date have been
conducted in mice. The inability to genetically manipu-
late mammalian mtDNA has made the study of patho-
genic heteroplasmies in mouse models challenging.
Early studies relied on fusing cytoplasts from two dif-
ferent mouse strains to generate conplastic hetero-
plasmic animals carrying two separate mtDNA
genotypes. Jenuth et al. (1996) studied segregation of
heteroplasmy in conplastic NZB/BALBc mice, conclud-
ing that the variance of this non-pathogenic hetero-
plasmy in germline cells was due to random genetic
drift. Using a similar approach, Meirelles and Smith
(1997) generated a conplastic NZB/C57Bl6 mouse
strain and saw evidence of stable heteroplasmy across
generations, contrasting the variance seen by Jenuth
et al. (1997), and inconsistent with the existing bottle-
neck theories. Interestingly, Sharpley et al. (2012)
found that mixing of mtDNA from the NZB and 129S6
strains resulted in animals that developed pathogenic
phenotypes, a phenomenon also seen by Acton et al.
(2007) in NZB/BALBc conplastic mice. Sharpley et al.
(2012) showed that heteroplasmy in NZB/129S6 mice
segregated rapidly towards 129S6 homoplasmy over
successive generations, suggesting active selection
against transmission of NZB mtDNA. These contrast-
ing results highlight the complex nature of mtDNA
inheritance, and suggest that pathogenic and non-
pathogenic heteroplasmies may segregate differently,
and may be influenced by the nuclear genetic back-
ground.
More recently, several groups have been able to gen-
erate mice harboring deleterious heteroplasmic mtDNA
mutations, allowing more detailed investigation of how
pathogenic variants are transmitted through the germ-
line. Fan et al. (2008) used a complex approach involv-
ing cytoplast fusion of mouse ES cells, and subsequent
injection into C57Bl/6 blastocysts, to introduce two
heteroplasmic mutations into the mtDNA of a single
female mouse. One mutation was a highly deleterious
frame-shift in the ND6 gene, and the second a less
severe missense mutation in the cytochrome c oxidase
I (COI) gene. Analysis of heteroplasmy levels in subse-
quent generations revealed rapid elimination of the sev-
ere ND6 mutant within four generations, whilst the
milder COI mutant persisted, despite causing myopa-
thy and cardiomyopathy in the mice that carried it (Fan
et al. 2008). These results suggest that purifying
selection may act rapidly against severe pathogenic
mutations, whilst allowing less severe variants to persist
in the population. In a separate study, Stewart et al.
(2008b) utilized the PolgA exo mtDNA mutator mouse
model to introduce random mutations into the maternal
mitochondrial genome and studied their transmission.
Using this approach, they also found evidence that
non-synonymous (i.e. possibly pathogenic) mutations in
protein coding sequences are rapidly purged over just
a few generations, lending further support to the
hypothesis that deleterious variants are subject to puri-
fying selection (Stewart et al. 2008b).
The point at which purifying selection occurs in the
mouse is currently not well defined. In the aforemen-
tioned study by Freyer et al. (2012), segregation of the
tRNAMet m.3875delC mutation was seen early in PGC
development, consistent with the presence of a germ-
line genetic bottleneck. However, evidence of purifying
selection against high levels of mutation was only seen
in postnatal tissues, and not during germline develop-
ment (Freyer et al. 2012). A similar study in mice carry-
ing a point mutation in the tRNAAla gene also identified
selection against high levels of heteroplasmy in subse-
quent generations, but there was no concurrent
increase in embryonic death, again suggesting that the
selection takes place at the cellular/organellar level
after birth (Kauppila et al. 2016). Despite these find-
ings, there is currently very little data available on the
transmission of pathogenic mtDNA mutations through
the mouse germline, and further work will be required
to fully understand the dynamics of purifying selection
in this context.
Evidence for and against purifying selection
in human pedigrees
Understanding heteroplasmy transmission in the
human germline presents an even greater challenge
than that faced in the mouse. This is partly due to the
difficulty of obtaining embryonic tissues for analysis
and the ethical constraints that must be considered
when dealing with such sensitive material, but also
because of the inherent problem of ascertainment bias
when obtaining pedigree data from an affected pro-
band (Wilson et al. 2016). Consequently, the number
of studies in this area is few, although a number of
groups have managed to make some progress in this
challenging field. Monnot et al. (2011), who analyzed
embryonic tissues from nine heteroplasmic females
carrying the common m.3243A>G mutation, responsi-
ble for mitochondrial encephalomyopathy, lactic acido-
sis and stroke-like episodes syndrome, found that
segregation appears to be governed by random
genetic drift during early embryonic development.
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Similar results were seen in oocytes and embryos for
both the m.3243A>G mutation (Brown et al. 2001) and
the m.8993T>G neuropathy, ataxia and retinitis pig-
mentosa mutation in (Blok et al. 1997; Steffann et al.
2006, 2007), suggesting that these variants are not
subject to purifying selection. However, it must be
noted that drawing firm conclusions from small-scale
studies such as these is difficult because reliable
statistics require many independent observations
(Wonnapinij et al. 2010). More recently, an analysis of
human pedigrees transmitting a number of common
pathogenic heteroplasmies found that, although the
rate of segregation appears to vary between different
mutations, there was no evidence of selection from
mother to offspring (Wilson et al. 2016).
Although the above studies all seem to argue against
purifying selection acting on mtDNA variants during
germline development, these findings contrast with
other similar studies; Rebolledo-Jaramillo et al. (2014)
sequenced mtDNA from 39 healthy mother–child pairs,
and found that most carried one or more low-level
heteroplasmies, some of which were disease associ-
ated. Analysis of these point mutations showed
reduced transmission of non-synonymous compared
with synonymous mutations, suggesting that poten-
tially pathogenic variants are selected against. Simi-
larly, Li et al. (2016) also identified selection against
novel deleterious mtDNA heteroplasmies in a large
dataset obtained from the Genomes of the Nether-
lands project. Furthermore, in vivo data from recent
analysis of oocytes from nine healthy women found
evidence of selection against potentially pathogenic
mtDNA variants during oogenesis, occurring between
the expulsion of the first and second polar bodies (De
Fanti et al. 2017). Finally, very recent data from Floros
et al. (2018), obtained from early-gestation human
embryos (Carnegie stages 12–21), suggests that non-
synonymous mtDNA mutations are indeed subject to
purifying selection during PGC development. These
conflicting results highlight the fact that our under-
standing of the complex mechanisms underpinning
mtDNA transmission is far from complete, and much
work remains to be done to fully elucidate this key
process.
Proposed mechanisms by which purifying
selection may occur
The mechanism(s) controlling purifying selection in the
mammalian germline are not clear, and there is cur-
rently much debate over whether this occurs purely by
random genetic drift or by active selection. Whilst this
issue remains unresolved, it is quite possible that the
underlying processes vary depending on the specific
mutation and the level of heteroplasmy present, with
the additional complications raised by the different
nuclear genetic backgrounds.
Despite the evolutionary differences between mam-
mals and invertebrates alluded to previously, two
recent studies in model organisms have shed light on
potential mechanisms involved in the transmission of
heteroplasmic mtDNA mutations and warrant mention
here as potential pathways of interest to investigate
further in mammals. Hill et al. (2014) generated a
mutant Drosophila line carrying a temperature-sensitive
mtDNA heteroplasmy in the COI gene. During oogene-
sis, they found that wild-type mtDNA from “healthy”
mitochondria was preferentially amplified over those
containing high levels of the mutant version, suggest-
ing that selection against heteroplasmy is dependent
upon “mitochondrial fitness”. In contrast, Lin et al.
(2016) engineered a C. elegans strain harboring an
mtDNA deletion heteroplasmy, and identified that the
mitochondrial unfolded protein response (UPRmt) plays
an important role in maintenance of this deleterious
mutation. It remains to be seen whether either of these
proposed mechanisms plays any role in mammalian
cells, although recent data from Pezet and colleagues
has failed to identify UPRmt activation in human cybrids
carrying a heteroplasmic mtDNA deletion, suggesting
that this mechanism is not involved in maintenance of
heteroplasmy in human cell lines (Mikael Pezet, unpub.
data, 2017).
In mice, Battersby and Shoubridge (2001) attempted
to identify the mechanism underlying preferential seg-
regation of NZB mtDNA in liver tissue of NZB/BALBc
conplastic animals (Jenuth et al. 1997). They con-
cluded that selection against BALBc mtDNA was not
due to growth defects or altered OXPHOS capacity,
but instead likely depended upon factors involved in
mtDNA maintenance (Battersby & Shoubridge 2001).
Subsequently, Moreno-Loshuertos et al. (2006)
reported that NZB/BALBc heteroplasmy does result in
altered OXPHOS efficiency due to an SNP in the
tRNAArg gene, the effects of which are masked by
compensatory mechanisms triggered by upregulation
of ROS production. However, these findings were
refuted by Battersby and Shoubridge (2007), and
Freyer et al. (2012) have since published further evi-
dence that selection against heteroplasmy is not
dependent upon OXPHOS function. Thus, a definitive
mechanism for this selection remains elusive in this
context. In the same NZB/BALBc model, Jokinen
et al. (2015) studied the preferential selection for
BALBc mtDNA in hematopoietic cells and found that
the tail-anchored, ER-resident GTPases Gimap3 and
Gimap5 play a critical role in mtDNA segregation, sug-
gesting that coordination of organelle interactions may
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be involved in modulating mtDNA segregation and
selection.
Studies investigating these selective mechanisms in
humans are similarly sparse. Blok et al. (1997) sug-
gested preferential amplification of a subset of mito-
chondrial genomes, possibly similar to that seen in
Drosophila (Hill et al. 2014), to explain skewed segre-
gation of the m.8993T>G mutation in human oocytes,
but there is no empirical human data to support this
theory. More recently, Ling et al. (2016) found that
fibroblasts carrying the m.3243A>G mutation showed
increased segregation towards homoplasmy following
treatment with ROS, and suggested that this was due
to formation of mtDNA concatemers that allow amplifi-
cation of multiple identical mtDNA copies as a single
unit. Whether this mechanism has any role in mtDNA
segregation during germline development is currently
not clear.
Current tools for studying purifying
selection in the germline
Although we currently understand very little about the
selective mechanisms active in the female germline,
recent advances in both murine and human reproduc-
tive biology have provided important new tools that are
likely to aid the further investigation of this important
subject. Here, we discuss the current in vitro and
in vivo technologies that exist to enable study of
female germline development and mtDNA
transmission.
In vitro models to investigate germline
mtDNA transmission
It is only recently that induced pluripotent stem (iPS)
cells derived from patients carrying heteroplasmic
mtDNA variants have been used to understand the tis-
sue specificity of mitochondrial diseases and to study
the impact of the heteroplasmy upon cell fate (Cherry
et al. 2013; Folmes et al. 2013; Hamalainen et al.
2013). These iPS-derived cell models represent a
potential tool to investigate the underlying disease
mechanisms, but also to screen for new therapeutic
drugs in a tissue-specific manner (Hatakeyama & Goto
2016). This is possibly due to our comprehensive
understanding of the molecular pathways involved in
the differentiation of the iPS cells into different cell lin-
eages. Such mechanisms, although already well
established in iPS cells, have also been intensively
studied in the context of PGC specification in recent
years.
The PGC are specified from the proximal epiblast by
BMP signaling from the extra-embryonic tissues. This
was first identified in homozygous BMP4 knockout
mice, which do not develop and PGC, and a similar,
but less drastic, phenotype was also observed in
BMP8b null mice (Lawson et al. 1999; Ying et al.
2000). BMP signaling activates Blimp-1, a key tran-
scriptional regulator that is first expressed at E6.25 in
mouse embryos. When Blimp1 expression is dis-
rupted, the number of founder PGC drops from 40 to
20 and they no longer migrate to the genital ridge,
where the future gonads will be formed (Ohinata et al.
2005). BMP signaling also activates expression of Prd-
m14, followed by Tcfap2c, which encodes the tran-
scription factor AP2c. Together Blimp1, Prdm14 and
AP2c control PGC specification and are able to rescue
this process when expressed in the absence of BMP
signaling (Magnusdottir et al. 2013). Further factors
involved in PGC development were identified by Saitou
et al. (2002) in a screen for PGC-specific genes. They
identified FGF-8, a gene that is expressed in the early
stages of PGC specification, and Stella, whose expres-
sion is germ cell-specific at E7.25 and continues to be
expressed in migrating PGC. This detailed understand-
ing of PGC specification has enabled the in vitro
induction of mouse and human ES cells, using growth
factors including BMP4, BMP8 and bFGF, to produce
primordial germ cell-like cells (PGCLC), which recapitu-
late the gene expression profile of in vivo PGC (Haya-
shi & Saitou 2013; Sugawa et al. 2015). As proof of
the robustness of this in vitro model, Hayashi et al.
aggregated PGCLC with gonadal cells, which were
then into mice depleted of endogenous PGC. These
mice were subsequently bred and produced healthy
offspring (Hayashi et al. 2012). Similarly, Hikabe et al.
have reconstituted in vitro the entire cycle of mouse
female germline. Using mouse ES cells, they were able
to generate fully mature oocytes that could also give
rise to healthy offspring when fertilized and transferred
to surrogate mothers (Hikabe et al. 2016).
In the same way that iPS cells have expanded our
understanding of the tissue specificity of mitochondrial
diseases, in vitro modeling using PGCLC or mature
oocytes derived from mouse and human ES cells are
likely to represent a malleable tool to study the precise
timing and mechanisms underpinning the transmission
of mtDNA variants during oogenesis.
Mouse models for in vivo study of mtDNA
transmission
In addition to the use of in vitro PGCLC, there are also
a number mouse models that allow in vivo examination
of mtDNA inheritance, and several of these have
already been discussed. A number of groups have
generated artificial heteroplasmies by mixing mtDNA
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from different mouse strains. This approach has a
number of drawbacks: first, unlike pathogenic variants
in human mtDNA caused by single point mutations,
the two mtDNA sequences in conplastic mice often
contain a large number of nucleotide differences (e.g.
91 polymorphisms exist between the NZB and 129S6
strains, including 15 non-synonymous variants [Sharp-
ley et al. 2012]). This makes dissection of any selective
mechanisms difficult, as multiple different factors may
contribute to the dynamics of segregation in these ani-
mals. Also, in many cases, these heteroplasmies are
not reported to be pathogenic (Jenuth et al. 1996;
Meirelles & Smith 1997), and therefore may not be
subject to purifying selection at all. Finally, introduction
of a “foreign” mtDNA invariably leads to a nuclear/
mtDNA mismatch within the cells, a situation that is
exacerbated if two mtDNA sequences are back-
crossed onto the nuclear background of a third strain
(Sharpley et al. 2012). Because nuclear/mtDNA mis-
matching in conplastic mice is known to impact upon
OXPHOS function and influence health and longevity
(Latorre-Pellicer et al. 2016), caution should be taken
when interpreting results from these studies, as there
is likely to be overlap between the effects of hetero-
plasmy and the mismatch with the nuclear genome.
The development of the PolgA exo mtDNA mutator
mouse, which acquires de novo heteroplasmic mtDNA
mutations due to an inactivating mutation in the proof-
reading subunit of the mtDNA polymerase gamma (Tri-
funovic et al. 2004), has resulted in a much more
tractable method for generating mice with genuine
heteroplasmies. However, the rapid and random intro-
duction of mutations into the mtDNA has made study-
ing the inheritance of individual mtDNA mutations
using this model challenging. By backcrossing PolgA
exo females with wild-type males, Freyer et al. (2012)
were able to generate a strain carrying just two mtDNA
mutations: a homoplasmic substitution, m.5245T>C, in
the tRNACys gene and a heteroplasmic deletion,
m.3875delC, in the tRNAMet gene. Although these
mice appeared phenotypically normal, a compensatory
transcriptional response was seen in tissues carrying
high levels of the tRNAMet mutant, suggesting that this
heteroplasmy was impacting mitochondrial function
(Freyer et al. 2012). More recently, Kauppila et al.
(2016) used a similar approach to obtain a strain carry-
ing a single heteroplasmic mutation at m.5024C>T in
the tRNAAla gene. Crucially, these animals develop car-
diomyopathy and the mutation appears to be selected
against in mitotic tissues, making this perhaps the best
model currently available for studying inheritance of
pathogenic mtDNA mutations in the mouse germline.
A number of tools exist to aid study of the mouse
germline, allowing effective identification and isolation
of PGC from their induction in the proximal epiblast at
embryonic day (E)6.25 (Ohinata et al. 2005) through to
oogenesis in late-stage embryos. Staining of embry-
onic cells for PGC markers, such as tissue non-speci-
fic alkaline phosphatase (Ginsburg et al. 1990), Stella
(Dppa3) (Saitou et al. 2002) and Blimp1 (Prdm1) (Ohi-
nata et al. 2005) allows efficient identification of PGC
during early embryonic development; however, use of
such stains and antibodies requires fixed tissues, limit-
ing this approach to non-living material. To enable
more versatile studies in live cells, Payer et al. (2006)
generated transgenic mice expressing a GFP-tagged
version of the PGC-specific marker Stella, which
allows non-invasive identification of PGC from E7.5
onwards. Ohinata et al. (2008) subsequently built upon
this model, creating a double-transgenic reporter
mouse expressing enhanced cyan fluorescent protein
(ECFP)-tagged Stella and mVenus-tagged Blimp1. In
this strain, Blimp1-mVenus expression is seen from
E7.5, with Stella-ECFP detectable from E8.5, allowing
for robust identification of double-positive PGC. Cross-
ing transgenic PGC reporter mice with females carry-
ing mtDNA mutations, such as the m.5024C>T
tRNAAla mutant, should enable detailed investigation of
the dynamics involved in germline transmission of
pathogenic mtDNA heteroplasmies and has the poten-
tial to dramatically expand our knowledge of this piv-
otal process.
Studying the human germline in vivo
In vivo study of human germline development is
incredibly challenging and fraught with ethical and
technical difficulties. Whilst some data is available from
oocytes and early embryos of patients carrying patho-
genic heteroplasmies (Blok et al. 1997; Brown et al.
2001; Monnot et al. 2011), successful isolation of pri-
mary PGC from human embryos has not been
reported. However, recently developed flow cytometry-
based protocols have been developed allowing the
isolation of human PGC from Carnegie stage 12
onwards (Tang et al. 2015; Floros et al. 2018), repre-
senting a significant advance in our ability to investi-
gate development of the human germline.
Conclusions and perspectives
In recent years, huge advances have been made in
the field of inherited mitochondrial disease, with a
number of therapeutic approaches, such as pre-
implantation genetic screening (Smeets et al. 2015)
and mitochondrial replacement therapy (Wolf et al.
2015), offering hope to families affected by these dev-
astating conditions. However, despite the large
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number of studies aimed at understanding how
heteroplasmic mtDNA mutations are transmitted
through the germline, many of the mechanisms
involved remain elusive, hampering efforts to develop
more effective treatment and prevention strategies.
The recent development of novel model systems and
in vivo techniques for detailed investigation of germline
development, both in humans and other mammals, pro-
mises to begin shedding light on some of the key unan-
swered questions that remain regarding mtDNA
transmission, and will hopefully lead to tangible progress
in the ongoing fight against mitochondrial disease.
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